IP Library Granted Patent US 7,714,147
Granted Patent B2
US 7,714,147 · App. 12/215,217 · Granted May 11, 2010

Method for preparing Fmoc-based hydrolysable linkers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,714,147
App. No.
12/215,217
Granted
May 11, 2010
Kind
B2
Abstract

A novel process for the production of Fmoc (9H-fluoren-9-ylmethoxycarbonyl)-based compounds is provided, wherein a protecting group for the 9-hydroxymethyl group of the fluorene ring system is utilized. These compounds are useful for the modification of protein and peptide drugs.

Claims (27)

1. A method of preparing a compound according to formula 1:

wherein PG is a silyl protecting group and at least one of position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to radical Y;

Y is a radical containing a N-maleimidyl-moiety having a structure

R 1 is a (C 1 -C 8 )-alkyl;

R 2 is selected from the group consisting of —C(O)NR—, —C(O)NR—(C 1 -C 8 )-alkyl-NR—, —NRC(O)— and —NRC(O)—(C 1 -C 8 )-alkyl-NR, wherein R is independently either hydrogen or C 1 -C 8 -alkyl;

at least one of an available position 1, 2, 3, 4, 5, 6, 7 or 8 is optionally bound to radical X;

X is —SO 3 R 3 ;

R 3 is independently selected from the group consisting of hydrogen, (C 1 -C 8 )-alkyl and (C 1 -C 8 )-alkyl-R 4 ; and

R 4 is a polymer;

said method comprises the steps of

reacting the 9-hydroxymethyl group of a compound of formula 2:

wherein at least one of position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to an amine, with a silyl protecting reagent introducing PG,

and subsequently reacting said compound with an N-maleimidyl reagent to form the compound of formula (1).

2. The method according to claim 1 , wherein said silyl protecting reagent is a silyl halide.

3. The method according to claim 2 , wherein said halide is tert-butyldimethylsilyl chloride (tBDMS-Cl).

4. The method according to claim 3 , wherein said reaction with tBDMS-Cl is performed with imidazole in dimethylformamide (DMF).

5. The method according to claim 4 , wherein said N-maleimidyl-reagent is maleimidoalkylic acid.

6. The method according to claim 3 , wherein at least one of an available position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to radical X.

7. A compound of the formula 1,

wherein PG is a silyl protecting group and at least one of position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to radical Y; and at least one of an available position 1, 2, 3, 4, 5, 6, 7 or 8 is optionally bound to radical X;

Y is a N-maleimidyl-containing moiety having a structure:

X is —SO 3 R 3 —;

R 3 is independently selected from the group consisting of hydrogen, (C 1 -C 8 )-alkyl and (C 1 -C 8 )-alkyl-R 4 ;

R 4 is a polymer;

R 1 is a (C 1 -C 8 )-alkyl; and

R 2 is selected from the group consisting of —C(O)NR—, —C(O)NR—(C 1 -C 8 )-alkyl-NR—, NRC(O)— and —NRC(O)—(C 1 -C 8 )-alkyl-NR—, wherein R is hydrogen or C 1 -C 8 -alkyl.

8. The compound according to claim 7 , wherein PG is a t-butyldimethylsilyl protecting group.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0005 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036362/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036374/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2010
From: TURECEK, PETER; SIEKMANN, JUERGEN; NOE, CHRISTIAN; STOIBER, GERHARD
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 024101/0966 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2008
From: TURECEK, PETER, MR.; SIEKMANN, JUERGEN, MR.; NOE, CHRISTIAN, MR.; STOIBER, GERHARD, MR.
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 021529/0098 →